Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,666   1.18  Index Moved Down -0.07%
TMO A A DGX Precious Metals Toys Office Supplies Drugs 
United States  USA  |  Screen Global Equities


Processing
Processing. Please wait...

Genomic Shares Outstanding

 
 Companies |  Insiders  | Dashboard  
     

Shares Outstanding breakdown for Genomic

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.

Genomic

Shares Outstanding

=

Public Shares

-

Repurchased

=
30.12 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Compare Genomic to competition

Genomic Shares Outstanding Assessment

Based on latest financial disclosure Genomic Health Inc has 30.12 M of shares currently outstending. This is 86.59% lower than that of Healthcare sector, and 88.08% lower than that of Medical Laboratories and Research industry, The Shares Outstanding for all stocks is 89.84% higher than the company.

Filter other Stocks by Shares Outstanding

Specify Market Cap
Select Shares Outstanding Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  

Shares Outstanding Comparison

Genomic is currently under evaluation in shares outstanding category among related companies.
Follow Genomic Shares Outstanding with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Genomic to your reader
 
    
GHDX United States Nasdaq
Genomic Health Inc
Currency: USD - US Dollar
Traded on NASDAQ
    
    

Other Genomic Fundamentals

Return On Equity6.83 %
Return On Asset3.55 %
Profit Margin3.51 %
Operating Margin3.59 %
Current Valuation807.43 M
Shares Outstanding30.12 M
Shares Owned by Insiders52.63 %
Shares Owned by Institutions45.70 %
Number of Shares Shorted2.43 M
Price to Earning115.77 times
Price to Book7.14 times
Price to Sales3.85 times
Revenue235.17 M
Gross Profit198.16 M
EBITDA13.9 M
Net Income8.25 M
Cash and Equivalents99.07 M
Cash per Share3.29 times
Current Ratio5.14 times
Book Value Per Share4.22 times
Cash Flow from Operations25.96 M
Short Ratio13.20 times
One Year High37.44
One Year Low25.25
Earnings Per Share0.26 times
Price to Earnings To Growth42.08 times
Number of Employees612
Beta0.32
Market Capitalization906.46 M
Total Asset153.73 M
Retained Earnings(157.51 M)
Working Capital104.87 M
Current Asset130.21 M
Current Liabilities25.34 M
Z Score-0.401
Probability Of Bankruptcy64.81 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium